TipRanks
Advertisement

ISCB - ETF AI Analysis

Compare

Top Page

ISCB

iShares Morningstar Small-Cap ETF (ISCB)

Rating:66Neutral
Price Target:―
ISCB’s rating suggests it is a solid but not top-tier small-cap ETF, with its quality driven by several strong, growing companies but tempered by some risks. Standout holdings like Okta and Zebra Technologies support the fund with strong financial performance, strategic growth initiatives, and positive momentum, while names like Guardant Health and Nutanix introduce more risk due to financial instability, leverage, and valuation concerns. The main risk factor is exposure to companies with profitability and valuation challenges, which can make the ETF more sensitive to market volatility.
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and over the past few months, showing solid recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors, including industrials, financials, health care, technology, and consumer stocks, which helps reduce the impact of weakness in any single area.
Very Low Expense Ratio
The fund’s expense ratio is low, which means investors keep more of the returns instead of paying high management fees.
Negative Factors
Heavy U.S. Concentration
Almost all of the ETF’s assets are invested in U.S. companies, offering very little geographic diversification.
Small-Cap Volatility Risk
Because the fund focuses on small-cap stocks, it may experience larger price swings and higher risk than funds holding bigger, more established companies.
Top Holdings in Volatile Growth Names
Several of the largest positions are in growth-oriented companies that can be more sensitive to changes in investor sentiment and market conditions.

ISCB vs. SPDR S&P 500 ETF (SPY)

ISCB Summary

The iShares Morningstar Small-Cap ETF (ISCB) is a fund that follows the Morningstar US Small Cap Extended Market Index, focusing on smaller U.S. companies with room to grow. It owns a wide mix of businesses across many sectors, including technology, health care, and financials. Well-known names in the fund include Roku and Best Buy. Someone might invest in ISCB to add diversification and growth potential to a portfolio by tapping into smaller, more agile companies. A key risk is that small-cap stocks can be more volatile, so the ETF’s value can rise and fall more sharply than the overall market.
How much will it cost me?The iShares Morningstar Small-Cap ETF (ISCB) has an expense ratio of 0.04%, which means you’ll pay $0.40 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down.
What would affect this ETF?The iShares Morningstar Small-Cap ETF (ISCB) could benefit from economic growth and innovation in sectors like technology and healthcare, which make up a significant portion of its holdings. However, small-cap stocks are often more sensitive to interest rate hikes and economic slowdowns, which could negatively impact the ETF's performance. Additionally, its focus on U.S.-based companies means it may be affected by domestic regulatory changes or geopolitical events.

ISCB Top 10 Holdings

ISCB is leaning into U.S. small-cap growth, with a clear tilt toward tech and innovation. Okta and Rubrik have been rising, helping power returns as investors warm to security and data-focused names. Dynatrace and Nutanix add more software firepower, though their mixed, sometimes cautious trading keeps the ride bumpy. On the health care side, Guardant Health and Revvity are climbing but still wrestling with profitability, which can cap their impact. Overall, the fund is driven by a cluster of smaller, fast-moving tech and health names rather than any single giant.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Moderna1.19%$3.24M$89.83B738.61%
59
Neutral
Tenet Healthcare0.36%$970.97K$21.24B39.14%
74
Outperform
MACOM Technology Solutions Holdings0.35%$969.06K$25.21B170.14%
64
Neutral
US Foods Holding0.34%$917.40K$21.08B29.63%
74
Outperform
Viatris0.32%$878.68K$20.26B81.11%
60
Neutral
Guardant Health0.32%$878.38K$22.47B160.78%
61
Neutral
Roku0.32%$864.06K$22.70B66.10%
65
Neutral
Royal Gold0.31%$857.75K$20.02B21.47%
78
Outperform
Woodward0.31%$854.88K$19.81B35.72%
79
Outperform
TD SYNNEX Corporation0.31%$847.17K$21.81B80.28%
73
Outperform

ISCB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price―
Price Trends
50DMA
74.22
Negative
100DMA
73.65
Negative
200DMA
70.63
Positive
Market Momentum
MACD
-0.64
Negative
RSI
43.34
Neutral
STOCH
34.57
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ISCB, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 72.24, equal to the 50-day MA of 74.22, and equal to the 200-day MA of 70.63, indicating a neutral trend. The MACD of -0.64 indicates Negative momentum. The RSI at 43.34 is Neutral, neither overbought nor oversold. The STOCH value of 34.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ISCB.

ISCB Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
――$273.45M0.04%
66
Neutral
――$820.97M0.49%
68
Neutral
――$790.42M0.48%
72
Outperform
――$729.90M0.09%
62
Neutral
――$690.52M0.42%
68
Neutral
――$680.70M0.38%
67
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ISCB
iShares Morningstar Small-Cap ETF
71.58
9.04
14.45%
SFLO
VictoryShares Small Cap Free Cash Flow ETF
―
―
―
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
―
―
―
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
―
―
―
JHSC
John Hancock Multifactor Small Cap ETF
―
―
―
EES
WisdomTree U.S. SmallCap Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement